Brain

AmblyoPlay Launches New Technology for Greater Peripheral Vision Stimulation

Idrija, Slovenia--(Newsfile Corp. - October 15, 2024) - AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch…

3 months ago

Children’s Brain Tumor Network Dataset Now Accessible on Kids First Data Resource Center Portal

PHILADELPHIA, Oct. 15, 2024 /PRNewswire/ -- The Gabriella Miller Kids First Data Resource Center (Kids First DRC) announces the addition…

3 months ago

Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’

- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease…

3 months ago

Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

KELOWNA, BC / ACCESSWIRE / October 15, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator…

3 months ago

Perceiv AI Welcomes Simona Skerjanec to Board of Directors

Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE…

3 months ago

Natus to showcase game-changing innovations at Neurocritical Care Society Conference

MIDDLETON, Wis., Oct. 14, 2024 /PRNewswire/ -- Natus Medical Incorporated's innovation in ICU solutions will be on display Oct. 14-18,…

3 months ago

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology…

3 months ago

RETRANSMISSION: Top Young Innovator Announces Dallas-Based Hisham Ahmad as America’s “Top Young Innovator 2024”

DiscoverSTEM Celebrates Innovation with Award-Winning Solutions from Youth Innovators Across the USA and UAE.This release is being retransmitted to correct…

3 months ago

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the…

3 months ago